Buy Turning Point Therapeutics Stock | TPTX Stock Price & Latest News | Public
TPTX

Turning Point Therapeutics

$0.00 (0.00%)Today

    About TPTX

    Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by J. Jean Cui...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.56
    -1.13
    -1.69
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.81

    Actual EPS
    Q3 2020

    Stats

    Market Cap$3,65B
    Volume7,75k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$89.30
    1 Year Low$31.30
    Open$83.27
    High$86.72
    Low$82.95

    Buy any stock with any amount of money.

    Download the App
    Download the app